MedStartr

xRapid Group is an international start-up created in 2015 and composed of 25 collaborators. Located in France, Great Britain, the United States and China, it launched an application to detect malaria in 2015, fiber analysis in 2018, and has just won an innovation award in the health and wellness category at CES 2020 in Las Vegas for its at-home blood tests. The team working on the xRcovid project is made up of health and blood biochemistry experts, as well as professionals in artificial intelligence and real-time diagnostic image analysis

Projects Created

xRcovid

The first mobile app for Covid-19 Testing and Diagnosis

MedStartr
Index Score

xRcovid can analyse and monitor results from RDTs (rapid diagnostic serological tests) for Covid-19. Thanks to its AI, the app can guarantee the reliability of the test and the cla...

Aix-en-Provence, France

$ 100,000 goal

18 Likes
Partner
Mentor
This campaign has ended but you can still get involved.

6 Followers
Pilot
Donate
Learn more

COVID-19 Biotech

Company Contacts

Address:

Avenue Louis Philibert Domaine du Petit Arbois Bâtiment Poincaré

Aix-en-Provence, 13

FR 13290

Website URL:

xrapid-group.com/

04 42 94 49 72

Social Links:

@XrapidG

linkedin.com/company/18624661/admin/

Connect With Us

Jean Viry-Babel

Contact Person

Important Disclosure: MedStartr.com is a website owned and operated by MedStartr, Inc., which is not a broker-dealer, funding portal or investment advisor; and neither the website nor MedStartr, Inc. participate in the offer or sale of securities. All securities related activity is conducted through Young America Capital, LLC, a registered broker-dealer and member of FINRA/SIPC. No communication, through this website, email or in any other medium, should be construed as a recommendation for any securities offering.